Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
According to Johnson & Johnson's latest financial reports the company's current revenue (TTM) is $89.65 B. In 2022 the company made a revenue of $91.14 B a decrease over the years 2021 revenue that were of $93.77 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $93.02 B | 2.06% |
2022 | $91.14 B | -2.8% |
2021 | $93.77 B | 13.55% |
2020 | $82.58 B | 0.64% |
2019 | $82.05 B | 0.59% |
2018 | $81.58 B | 6.71% |
2017 | $76.45 B | 6.34% |
2016 | $71.89 B | 2.59% |
2015 | $70.07 B | -5.73% |
2014 | $74.33 B | 4.23% |
2013 | $71.31 B | 6.08% |
2012 | $67.22 B | 3.37% |
2011 | $65.03 B | 5.59% |
2010 | $61.58 B | -0.5% |
2009 | $61.89 B | -2.9% |
2008 | $63.74 B | 4.34% |
2007 | $61.09 B | 14.57% |
2006 | $53.32 B | 5.56% |
2005 | $50.51 B | 6.69% |
2004 | $47.34 B | 13.1% |
2003 | $41.86 B | 15.33% |
2002 | $36.29 B | 11.7% |
2001 | $32.49 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Novartis NVS | $49.92 B | -44.32% | ๐จ๐ญ Switzerland |
Pfizer PFE | $58.49 B | -34.76% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $40.10 B | -55.26% | ๐บ๐ธ USA |
Medtronic MDT | $32.32 B | -63.95% | ๐ฎ๐ช Ireland |
Eli Lilly LLY | $35.93 B | -59.92% | ๐บ๐ธ USA |
Sanofi SNY | $50.51 B | -43.66% | ๐ซ๐ท France |
Gilead Sciences GILD | $27.11 B | -69.76% | ๐บ๐ธ USA |
Stryker Corporation SYK | $20.96 B | -76.62% | ๐บ๐ธ USA |
Merck MRK | $60.11 B | -32.95% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $38.54 B | -57.01% | ๐ฌ๐ง UK |